IDH1 and central nervous system cancer: Derks and colleagues showed in a cohort of 54 diffuse glioma patients how patients with isocitrate dehydrogenase-mutated (IDH-mut) glioma have a better prognosis but suffer more often of epilepsy with respect to patients with IDH-wild type glioma, who are generally older and more often have neuropsychological deficits (75).